Infectious Disease Archives - Pharmaceutical Technology https://www.pharmaceutical-technology.com/sector/therapy-area/infectious-disease/ The leading site for news and procurement in the pharmaceutical industry Mon, 19 Aug 2024 16:10:34 +0000 en-US hourly 1 https://wordpress.org/?v=6.6.1 https://www.pharmaceutical-technology.com/wp-content/uploads/sites/24/2022/01/cropped-Pharmaceutical-Technology-Favicon-150x150.png Infectious Disease Archives - Pharmaceutical Technology https://www.pharmaceutical-technology.com/sector/therapy-area/infectious-disease/ 32 32 South African president calls on WHO for better mpox response https://www.pharmaceutical-technology.com/news/south-african-president-calls-on-who-for-better-mpox-response/ Mon, 19 Aug 2024 16:10:15 +0000 https://www.pharmaceutical-technology.com/news/south-african-president-calls-on-who-for-better-mpox-response/ Noumed’s Pharmaceutical Manufacturing Facility, Adelaide, Australia https://www.pharmaceutical-technology.com/projects/noumed-pharmaceutical-manufacturing-facility-adelaide-australia/ Thu, 15 Aug 2024 08:54:13 +0000 https://www.pharmaceutical-technology.com/?post_type=projects&p=326319 AN2 slashes staff by 50% after lead antibiotic flunks in Phase II/III trial https://www.pharmaceutical-technology.com/news/an2-slashes-staff-by-50-after-lead-antibiotic-flunks-in-phase-ii-iii-trial/ Fri, 09 Aug 2024 13:26:31 +0000 https://www.pharmaceutical-technology.com/news/an2-slashes-staff-by-50-after-lead-antibiotic-flunks-in-phase-ii-iii-trial/ Valneva and LimmaTech partner for shigellosis vaccine development https://www.pharmaceutical-technology.com/news/valneva-and-limmatech-partner-for-shigellosis-vaccine-development/ Thu, 01 Aug 2024 15:26:25 +0000 https://www.pharmaceutical-technology.com/news/valneva-and-limmatech-partner-for-shigellosis-vaccine-development/ SII and Oxford University’s malaria vax launched in Côte d’Ivoire https://www.pharmaceutical-technology.com/news/sii-oxford-university-vaccine-cote-d-ivoire/ Tue, 16 Jul 2024 09:31:49 +0000 https://www.pharmaceutical-technology.com/news/sii-oxford-university-vaccine-cote-d-ivoire/ AusperBio secures funding to advance AHB-137 for CHB https://www.pharmaceutical-technology.com/news/ausperbio-funding-chb/ Mon, 15 Jul 2024 09:22:28 +0000 https://www.pharmaceutical-technology.com/news/ausperbio-funding-chb/ BARDA and Tiba Biotech link to develop ‘flu therapeutics https://www.pharmaceutical-technology.com/news/barda-tiba-biotech-therapeutics-influenza/ Fri, 12 Jul 2024 07:35:39 +0000 https://www.pharmaceutical-technology.com/news/barda-tiba-biotech-therapeutics-influenza/ Emergent scores US medical countermeasure contracts worth over $250m https://www.pharmaceutical-technology.com/news/emergent-scores-us-medical-countermeasure-contracts-worth-over-250m/ Wed, 03 Jul 2024 14:05:10 +0000 https://www.pharmaceutical-technology.com/news/emergent-scores-us-medical-countermeasure-contracts-worth-over-250m/ UK’s new Netflix-style funding model for antibiotics goes live https://www.pharmaceutical-technology.com/features/uks-new-netflix-style-funding-model-for-antibiotics-goes-live/ Fri, 14 Jun 2024 07:00:00 +0000 ESCMID 2024: Using AI in infection prevention and control https://www.pharmaceutical-technology.com/analyst-comment/escmid-2024-using-ai-in-infection-prevention-and-control/ Mon, 29 Apr 2024 00:25:20 +0000 https://www.pharmaceutical-technology.com/analyst-comment/escmid-2024-using-ai-in-infection-prevention-and-control/